Controlled trials of antimicrobial chemotherapy for legionnaires' dise
ase have not been performed, although erythromycin and tetracycline ap
pear to be effective therapies. Laboratory data indicate that the acti
vities of the fluoroquinolone and newer macrolide/azalide agents again
st Legionella pneumophila are superior to that of erythromycin, and ca
se reports substantiate that the activities of these agents are at lea
st equal. Results of clinical treatment with and laboratory testing of
macrolides, tetracyclines, co-trimoxazole, chloramphenicol, aminoglyc
osides, fluoroquinolones, beta-lactam agents, and streptogramins are r
eviewed. The drugs of choice for the treatment of legionnaires' diseas
e in immunocompromised or severely ill patients should be one of the f
luoroquinolone antimicrobials rather than erythromycin.